[1]
Devolder, M.E.C. et al. 2024. CLINICAL OUTCOMES OF LONG-TERM USE OF SGLT2 INHIBITORS IN PATIENTS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE. Revista Ibero-Americana de Humanidades, Ciências e Educação. 10, 8 (Aug. 2024), 2042–2052. DOI:https://doi.org/10.51891/rease.v10i8.15327.